CADTH recommends medical abortion reimbursement

By |April 20th, 2017|

Statement of Vicki Saporta, President and CEO of the National Abortion Federation Canada on the Canadian Agency for Drugs and Technologies in Health (CADTH) recommendation on Mifegymiso: We are pleased that CADTH has recommended that mifepristone and misoprostol be reimbursed for medical abortion care. CADTH’s recommendation will help make medical abortion care more widely accessible [...]